GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ArthroCare Corp (FRA:BQK) » Definitions » Piotroski F-Score

ArthroCare (FRA:BQK) Piotroski F-Score : 0 (As of Apr. 27, 2024)


View and export this data going back to . Start your Free Trial

What is ArthroCare Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

ArthroCare has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for ArthroCare's Piotroski F-Score or its related term are showing as below:


ArthroCare Piotroski F-Score Historical Data

The historical data trend for ArthroCare's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ArthroCare Piotroski F-Score Chart

ArthroCare Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.00 7.00 4.00 5.00 6.00

ArthroCare Quarterly Data
Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 5.00 5.00 6.00 4.00

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar14) TTM:Last Year (Mar13) TTM:
Net Income was -5.138 + 7.683 + 8.304 + 4.496 = €15.3 Mil.
Cash Flow from Operations was 19.738 + 10.773 + 9.159 + -14.882 = €24.8 Mil.
Revenue was 69.789 + 68.714 + 74.247 + 69.448 = €282.2 Mil.
Gross Profit was 48.016 + 47.114 + 52.102 + 48.888 = €196.1 Mil.
Average Total Assets from the begining of this year (Mar13)
to the end of this year (Mar14) was
(407.91 + 408.485 + 429.462 + 433.723 + 413.14) / 5 = €418.544 Mil.
Total Assets at the begining of this year (Mar13) was €407.9 Mil.
Long-Term Debt & Capital Lease Obligation was €0.0 Mil.
Total Current Assets was €222.9 Mil.
Total Current Liabilities was €37.9 Mil.
Net Income was 9.774 + 7.748 + 8.512 + 8.635 = €34.7 Mil.

Revenue was 73.09 + 67.465 + 73.865 + 71.293 = €285.7 Mil.
Gross Profit was 51.288 + 47.131 + 52.727 + 49.423 = €200.6 Mil.
Average Total Assets from the begining of last year (Mar12)
to the end of last year (Mar13) was
(354.87 + 385.346 + 388.934 + 396.078 + 407.91) / 5 = €386.6276 Mil.
Total Assets at the begining of last year (Mar12) was €354.9 Mil.
Long-Term Debt & Capital Lease Obligation was €0.0 Mil.
Total Current Assets was €266.9 Mil.
Total Current Liabilities was €37.4 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

ArthroCare's current Net Income (TTM) was 15.3. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

ArthroCare's current Cash Flow from Operations (TTM) was 24.8. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar13)
=15.345/407.91
=0.03761859

ROA (Last Year)=Net Income/Total Assets (Mar12)
=34.669/354.87
=0.09769493

ArthroCare's return on assets of this year was 0.03761859. ArthroCare's return on assets of last year was 0.09769493. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

ArthroCare's current Net Income (TTM) was 15.3. ArthroCare's current Cash Flow from Operations (TTM) was 24.8. ==> 24.8 > 15.3 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar14)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar13 to Mar14
=0/418.544
=0

Gearing (Last Year: Mar13)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar12 to Mar13
=0/386.6276
=0

ArthroCare's gearing of this year was 0. ArthroCare's gearing of last year was 0. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar14)=Total Current Assets/Total Current Liabilities
=222.922/37.945
=5.87487152

Current Ratio (Last Year: Mar13)=Total Current Assets/Total Current Liabilities
=266.867/37.443
=7.12728681

ArthroCare's current ratio of this year was 5.87487152. ArthroCare's current ratio of last year was 7.12728681. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

ArthroCare's number of shares in issue this year was 32.654. ArthroCare's number of shares in issue last year was 28.785. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=196.12/282.198
=0.69497303

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=200.569/285.713
=0.70199466

ArthroCare's gross margin of this year was 0.69497303. ArthroCare's gross margin of last year was 0.70199466. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar13)
=282.198/407.91
=0.69181437

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar12)
=285.713/354.87
=0.80512018

ArthroCare's asset turnover of this year was 0.69181437. ArthroCare's asset turnover of last year was 0.80512018. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+0+0+0+0
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

ArthroCare has an F-score of 4 indicating the company's financial situation is typical for a stable company.

ArthroCare  (FRA:BQK) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


ArthroCare Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of ArthroCare's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


ArthroCare (FRA:BQK) Business Description

Traded in Other Exchanges
N/A
Address
ArthroCare was incorporated in California in 1993 and reincorporated in Delaware in 1995. The Company is a multi-business medical device Company that develops, manufactures and markets minimally invasive surgical products, many of which are based on its patented Coblation(r) technology. The Company has grown well beyond its roots in arthroscopy to capitalize on numerous market opportunities across several medical specialties, improving many existing soft-tissue surgical procedures and enabling new minimally invasive procedures. With its innovative technologies, the Company is improving the lives of individuals suffering from conditions as diverse as torn rotator cuffs and anterior cruciate ligaments to herniated discs and enlarged tonsils/tonsillitis. The Company currently markets minimally invasive surgical products across three core business units-ArthroCare Sports Medicine, which include shoulder and knee arthroscopic products; ArthroCare Spine, which include spinal and neurosurgery products; and ArthroCare Ear, Nose and Throat, which include ear, nose, throat and the Visage(r) cosmetic products; - but also has developed, manufactured and marketed Coblation-based and complementary products for application in neurology, cosmetic surgery, urology and gynecology, with research continuing in additional areas. In each of its core business units, the Company is focusing on driving the application of enabling technologies, primarily for plasma-based soft tissue removal, and increasing the number of minimally invasive procedures being performed. The Company is marketing and selling its arthroscopic/sports medicine, spinal surgery, ENT and cosmetic surgery products using a combination of distributors supported by regional sales mangers, a direct sales force and corporate partners to sell its products both domestically and internationally. The Company owns over 170 issued U.S. patents and over 195 issued international patents. The Company's products are considered medical devices and are subject to regulation in the United States, with the approval of FDA for each of its products. Its primary competitors include Medtronic, Inc., Smith & Nephew, Stryker Corporation, Johnson & Johnson, Olympus (through its subsidiary Gyrus) and Arthrex, Inc.

ArthroCare (FRA:BQK) Headlines

No Headlines